Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Figure 3

Scatterplot highlighting the correlation between cfDNA input amount (x-axis) and limit of detection (LOD, y-axis).